Trial Profile
Safety and Efficacy of Sustained Erythropoietin Therapy of Anemia in End Stage Renal Disease (ESRD) Dialysis Patients Using EPODURE Biopump
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs MDGN 201 (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Aevi Genomic Medicine
- 15 May 2014 New trial record